Across India, more than 100 million people carry a diagnosis that quietly threatens something they may not yet know is at risk: their sight. Diabetic retinopathy, a condition that erodes the retina's blood vessels without warning, has become one of the leading preventable causes of blindness among working-age adults — yet it advances in near-total silence, asking nothing of its host until the damage is already done. The cruelty of this disease lies not in its inevitability but in its preventability: a single annual eye exam can reduce the risk of severe vision loss by 95 percent, transforming
India's 100M diabetics face silent vision threat from retinopathy
A person can lose significant vision before they notice anything is wrong.
Why does retinopathy develop so quietly? Why don't people feel it happening?
The retina has no pain receptors. The blood vessels are microscopic. Damage accumulates in the periphery of vision first, where the brain doesn't notice it as much. By the time the central vision blurs, months or years have passed.
So someone could be going blind and have no idea.
Exactly. That's the cruelty of it. A person can have perfect vision one day and wake up six months later with permanent damage that could have been stopped.
What does the screening actually involve?
A simple eye exam. A doctor looks at the retina through a special lens or uses a camera. The new AI technology they're deploying doesn't even require dilating the pupils. It takes minutes.
And if they find it early?
Treatment options exist—laser therapy, injections, surgery depending on the stage. But the earlier you catch it, the simpler and more effective the intervention. That 95 percent reduction in severe vision loss—that's what early detection buys you.
Why hasn't this message reached the 100 million diabetics in India already?
Diabetes care in India has historically focused on blood sugar control. The eye complications feel distant, abstract. People don't connect their daily glucose readings to their vision until it's too late. The campaign is trying to make that connection visible.
El Pulso
- With 100 million diabetics and climbing, India is sitting atop one of the world's largest populations at risk for preventable blindness — and most of them don't know it.
- Diabetic retinopathy offers no early warnings: vision can deteriorate dramatically before a person notices a single symptom, making complacency the disease's most dangerous ally.
- The gap between what medicine can prevent and what is actually being prevented is vast — the majority of diabetic Indians are not receiving the annual eye screenings that could save their sight.
- Sun Pharma's #SeeBeyondSugar campaign is deploying AI-powered screening technology across 300 camps in 28 cities, attempting to rewire how the country thinks about diabetes care beyond blood sugar alone.
- Specialists are urging a simple but radical shift: treat the annual eye exam not as an afterthought but as a non-negotiable pillar of diabetes management, on par with monitoring glucose levels.
Across India, more than 100 million people carry a diagnosis that quietly threatens something they may not yet know is at risk: their sight. Diabetic retinopathy, a condition that erodes the retina's blood vessels without warning, has become one of the leading preventable causes of blindness among working-age adults — yet it advances in near-total silence, asking nothing of its host until the damage is already done. The cruelty of this disease lies not in its inevitability but in its preventability: a single annual eye exam can reduce the risk of severe vision loss by 95 percent, transforming a potential tragedy into a manageable condition. India now stands at a crossroads between a silent epidemic and a solvable one.
More than 100 million Indians are living with diabetes, and the national conversation around the disease has a dangerous blind spot. While attention stays fixed on blood sugar numbers, a quieter complication is advancing through millions of bodies unannounced: diabetic retinopathy, which damages the retina's delicate blood vessels and ranks among the leading preventable causes of blindness in working-age adults.
The disease is both common and insidious. Nearly all Type 1 diabetics will develop some degree of retinopathy over their lifetime, and roughly 60 percent of those with Type 2 will as well. It moves in stages — beginning with symptomless vessel changes, progressing to oxygen starvation of the retina, then fragile new vessel growth, bleeding, scar tissue, and in the worst cases, full retinal detachment. Many people notice nothing until the damage is irreversible.
The deepest tragedy is that early detection changes everything. Annual screening can reduce the risk of severe vision loss by up to 95 percent. Dr. Manisha Agarwal of Dr. Shroff's Charity Eye Hospital stresses that Type 2 diabetics should be screened at diagnosis and every year thereafter, regardless of symptoms, while Type 1 patients should begin five years after diagnosis. Managing blood sugar, blood pressure, and cholesterol can slow progression — but only if the disease is caught in time.
To close the gap between what is preventable and what is actually being prevented, Sun Pharma has launched the #SeeBeyondSugar campaign alongside the Vitreo Retinal Society of India. Roughly 300 screening camps across 28 cities will use AI-powered technology capable of diagnosing retinopathy quickly and without pupil dilation. The campaign's ambition is cultural as much as clinical: to make eye care an expected part of diabetes management, not an afterthought.
For 100 million Indians already living with diabetes, the ask is modest — one eye exam a year. The return on that investment could be a lifetime of unimpaired sight.
More than 100 million Indians are living with diabetes right now, and that number keeps climbing. But the conversation about diabetes in this country has a blind spot—literally. While doctors and patients focus on managing blood sugar, one of the most serious complications of the disease moves through the body almost silently: diabetic retinopathy, a condition that damages the tiny blood vessels in the retina and stands as one of the leading preventable causes of blindness among working-age adults.
The mechanics are straightforward and grim. High blood sugar, sustained over years, erodes the delicate network of vessels at the back of the eye. The damage accumulates without fanfare. A person can lose significant vision before they notice anything is wrong. Nearly everyone with Type 1 diabetes will develop some degree of retinopathy in their lifetime. Among those with Type 2 diabetes—the far more common form in India—about 60 percent will experience it. The longer someone has diabetes, the higher the risk climbs.
The disease unfolds in stages, each one a step deeper into trouble. It begins with small changes in the blood vessels that cause no symptoms at all. As it progresses, more vessels become blocked, starving the retina of oxygen. The eye responds by trying to grow new vessels, but these are fragile and prone to bleeding. Scar tissue forms. The macula—the part of the retina responsible for sharp, central vision—swells. In the worst cases, the retina detaches entirely. Some people notice blurred vision, dark spots, or difficulty seeing at night. Many notice nothing until the damage is already severe.
This is where the tragedy deepens: early detection works. Annual eye screening can catch retinopathy before it causes irreversible harm. Medical experts say that catching the disease early and treating it promptly can reduce the risk of severe vision loss by up to 95 percent. Yet most people with diabetes in India are not getting screened. Dr. Manisha Agarwal, head of retina services at Dr. Shroff's Charity Eye Hospital in New Delhi, emphasizes that people with Type 1 diabetes should have their first eye exam five years after diagnosis, while those with Type 2 should be screened at the time of diagnosis and then annually, regardless of whether they notice any symptoms. She notes that controlling blood sugar, blood pressure, and cholesterol can slow the disease's progression once it has begun, but the key is catching it early.
Recognizing this gap between what could be prevented and what is actually being prevented, Sun Pharma has launched a nationwide campaign called #SeeBeyondSugar, backed by the Vitreo Retinal Society of India. The initiative is organizing roughly 300 eye screening camps across 28 cities, using AI-powered technology that can diagnose retinopathy quickly and without the need for pupil dilation. The goal is straightforward: shift how Indians think about diabetes management. It is not just about the numbers on a blood glucose meter. It is about preserving the ability to see.
The stakes are personal and profound. Diabetes may be a lifelong condition, but the blindness it can cause is preventable. A single eye exam once a year—a small investment of time—could be the difference between a life lived fully and one constrained by vision loss. For 100 million Indians already living with diabetes, and millions more who will develop it, that difference matters.
Citas Notables
People with type-1 diabetes should have their first eye exam five years after diagnosis, while those with type-2 should do so at the time of diagnosis, followed by annual check-ups even if there are no signs or symptoms.— Dr. Manisha Agarwal, HOD Retina, Dr. Shroff's Charity Eye Hospital, New Delhi
Awareness about Diabetic Retinopathy remains alarmingly low, even though it is one of the most serious complications of diabetes. Yearly eye check-ups can help save vision and transform lives.— Kirti Ganorkar, Managing Director, Sun Pharma